Your browser doesn't support javascript.
loading
Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies.
Pennells, Lisa; Kaptoge, Stephen; Wood, Angela; Sweeting, Mike; Zhao, Xiaohui; White, Ian; Burgess, Stephen; Willeit, Peter; Bolton, Thomas; Moons, Karel G M; van der Schouw, Yvonne T; Selmer, Randi; Khaw, Kay-Tee; Gudnason, Vilmundur; Assmann, Gerd; Amouyel, Philippe; Salomaa, Veikko; Kivimaki, Mika; Nordestgaard, Børge G; Blaha, Michael J; Kuller, Lewis H; Brenner, Hermann; Gillum, Richard F; Meisinger, Christa; Ford, Ian; Knuiman, Matthew W; Rosengren, Annika; Lawlor, Debbie A; Völzke, Henry; Cooper, Cyrus; Marín Ibañez, Alejandro; Casiglia, Edoardo; Kauhanen, Jussi; Cooper, Jackie A; Rodriguez, Beatriz; Sundström, Johan; Barrett-Connor, Elizabeth; Dankner, Rachel; Nietert, Paul J; Davidson, Karina W; Wallace, Robert B; Blazer, Dan G; Björkelund, Cecilia; Donfrancesco, Chiara; Krumholz, Harlan M; Nissinen, Aulikki; Davis, Barry R; Coady, Sean; Whincup, Peter H; Jørgensen, Torben.
Afiliação
  • Pennells L; Department of Public Health and Primary Care, University of Cambridge, 2 Worts' Causeway, Cambridge, UK.
  • Kaptoge S; Department of Public Health and Primary Care, University of Cambridge, 2 Worts' Causeway, Cambridge, UK.
  • Wood A; Department of Public Health and Primary Care, University of Cambridge, 2 Worts' Causeway, Cambridge, UK.
  • Sweeting M; Department of Public Health and Primary Care, University of Cambridge, 2 Worts' Causeway, Cambridge, UK.
  • Zhao X; Department of Physiology, Development and Neuroscience, University of Cambridge, Downing Street, Cambridge, UK.
  • White I; MRC Clinical Trials Unit, University College London, 90 High Holborn, London, UK.
  • Burgess S; Department of Public Health and Primary Care, University of Cambridge, 2 Worts' Causeway, Cambridge, UK.
  • Willeit P; MRC Biostatistics Unit, Cambridge Institute of Public Health, University of Cambridge, Forvie Site, Robinson Way, Cambridge, UK.
  • Bolton T; Department of Public Health and Primary Care, University of Cambridge, 2 Worts' Causeway, Cambridge, UK.
  • Moons KGM; Department of Neurology and Neurosurgery, Medical University of Innsbruck, Anichstraße 35, Innsbruck, Austria.
  • van der Schouw YT; Department of Public Health and Primary Care, University of Cambridge, 2 Worts' Causeway, Cambridge, UK.
  • Selmer R; Epidemiology: Methodology, Julius Center Research Program Methodology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht, the Netherlands.
  • Khaw KT; Department of Epidemiology, Julius Center Research Program Cardiovascular Epidemiology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht, the Netherlands.
  • Gudnason V; Division of Epidemiology, Norwegian Institute of Public Health, Postboks 222 Skøyen, Oslo, Norway.
  • Assmann G; Department of Public Health and Primary Care, University of Cambridge, 2 Worts' Causeway, Cambridge, UK.
  • Amouyel P; Icelandic Heart Association, Hjartavernd Holtasmá¡ri 1, Kópavogur, Iceland.
  • Salomaa V; Faculty of Medicine, University of Iceland, Vatnsmýrarvegur 16, Reykjavik, Iceland.
  • Kivimaki M; Assmann-Foundation for Prevention, Gronowskistraße 33, Münster, Germany.
  • Nordestgaard BG; Institut Pasteur de Lille, 1 rue du Professeur Calmette, Lille, France.
  • Blaha MJ; National Institute for Health and Welfare, Mannerheimintie 166, Helsinki, Finland.
  • Kuller LH; Department of Epidemiology and Public Health, University College London, 1-19 Torrington Place, London, UK.
  • Brenner H; Department of Clinical Medicine, Copenhagen University Hospital, Blegdamsvej 3, Copenhagen, Denmark.
  • Gillum RF; Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins Hospital, 1800 Orleans St, Baltimore, MD, USA.
  • Meisinger C; Department of Epidemiology, University of Pittsburgh, 200 Lothrop Street, Pittsburgh, PA, USA.
  • Ford I; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Neuenheimer Feld 581, Heidelberg, Germany.
  • Knuiman MW; University of Heidelberg, Grabengasse 1, Heidelberg, Germany.
  • Rosengren A; Department of Medicine, Howard University College of Medicine, 2041 Georgia Avenue, Washington, DC, USA.
  • Lawlor DA; German Research Center for Environmental Health, Ingolstädter Landstraße 1, Neuherberg, Germany.
  • Völzke H; Institute of Health & Wellbeing, University of Glasgow, Boyd Orr Building, University Avenue, Glasgow, UK.
  • Cooper C; Faculty of Health and Medical Sciences, School of Population and Global Health, University of Western Australia, 35 Stirling Highway, Perth, Western Australia, Australia.
  • Marín Ibañez A; Sahlgrenska Academy, University of Gothenburg, Medicinaregatan 3, Gothenburg, Sweden.
  • Casiglia E; Wallenberg Laboratory, Sahlgrenska University Hospital, Blå stråket 5, Gothenburg, Sweden.
  • Kauhanen J; Department of Social Medicine, University of Bristol, Bristol, UK.
  • Cooper JA; Institute of Community Medicine, University of Greifswald, Ellernholzstraße 1/2, Greifswald, Germany.
  • Rodriguez B; MRC Lifecourse Epidemiology Unit, University of Southampton, Tremona Rd, Southampton, UK.
  • Sundström J; San Jose Norte Health Centre, 16 Lugar De Santuario Cabañas, Zaragoza, Spain.
  • Barrett-Connor E; Department of Medicine, University of Padova, 2 Via Giustiniani, Padova, Italy.
  • Dankner R; Institute of Public Health and Clinical Nutrition, University of Eastern Finland, 1 Yliopistonranta, Kuopio, Finland.
  • Nietert PJ; Centre for Cardiovascular Genetics, University College London, 5 University Street, London, UK.
  • Davidson KW; Department of Geriatric Medicine, University of Hawaii, 1960 East-West Road, Honolulu, HI, USA.
  • Wallace RB; Department of Medical Sciences, Uppsala University, Ing 40, 5 tr, Uppsala, Sweden.
  • Blazer DG; University of California San Diego, 9500 Gilman Drive, La Jolla, CA, USA.
  • Björkelund C; Unit for Cardiovascular Epidemiology, The Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer, Israel.
  • Donfrancesco C; Department of Epidemiology and Preventive Medicine, Sackler Faculty of Medicine, School of Public Health, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel.
  • Krumholz HM; Department of Public Health Sciences, Medical University of South Carolina, 135 Cannon Street, Charleston, SC, USA.
  • Nissinen A; Department of Medicine, Columbia University Irving Medical Center, 622 West 168th Street, New York, NY, USA.
  • Davis BR; College of Public Health, University of Iowa, 145 N. Riverside Drive, Iowa City, IA, USA.
  • Coady S; Department of Surgery, Duke University Medical Center, 2301 Erwin Rd, Durham, NC, USA.
  • Whincup PH; Department of Public Health and Community Medicine, University of Gothenburg, Medicinaregatan 16, Gothenburg, Sweden.
  • Jørgensen T; Department of Cardiovascular, Dysmetabolic and Aging-Associated Diseases, Istituto Superiore di Sanità (ISS), 299 Viale Regina Elena, Rome, Italy.
Eur Heart J ; 40(7): 621-631, 2019 02 14.
Article em En | MEDLINE | ID: mdl-30476079
ABSTRACT

AIMS:

There is debate about the optimum algorithm for cardiovascular disease (CVD) risk estimation. We conducted head-to-head comparisons of four algorithms recommended by primary prevention guidelines, before and after 'recalibration', a method that adapts risk algorithms to take account of differences in the risk characteristics of the populations being studied. METHODS AND

RESULTS:

Using individual-participant data on 360 737 participants without CVD at baseline in 86 prospective studies from 22 countries, we compared the Framingham risk score (FRS), Systematic COronary Risk Evaluation (SCORE), pooled cohort equations (PCE), and Reynolds risk score (RRS). We calculated measures of risk discrimination and calibration, and modelled clinical implications of initiating statin therapy in people judged to be at 'high' 10 year CVD risk. Original risk algorithms were recalibrated using the risk factor profile and CVD incidence of target populations. The four algorithms had similar risk discrimination. Before recalibration, FRS, SCORE, and PCE over-predicted CVD risk on average by 10%, 52%, and 41%, respectively, whereas RRS under-predicted by 10%. Original versions of algorithms classified 29-39% of individuals aged ≥40 years as high risk. By contrast, recalibration reduced this proportion to 22-24% for every algorithm. We estimated that to prevent one CVD event, it would be necessary to initiate statin therapy in 44-51 such individuals using original algorithms, in contrast to 37-39 individuals with recalibrated algorithms.

CONCLUSION:

Before recalibration, the clinical performance of four widely used CVD risk algorithms varied substantially. By contrast, simple recalibration nearly equalized their performance and improved modelled targeting of preventive action to clinical need.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Algoritmos / Doenças Cardiovasculares Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Heart J Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Algoritmos / Doenças Cardiovasculares Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Heart J Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido